JAZZ Jazz Pharmaceuticals plc
JAZZ Jazz Pharmaceuticals plc
Healthcare · Biotechnology
Desk view
Market read
POC $166.06 · VWAP $200.77 · +4.7% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $19.2M sold last open-market sell Iannone Robert
Cluster CEO, EVP + 1 other sold $2.3M, Sep 2–14
Coverage
1 watchlist
JAZZ Price Structure
Loading timeframes…
Peers
Every watchlist JAZZ belongs to, members best 30-day change first — JAZZ highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How JAZZ's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about JAZZ from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 8 days ago · Oct 9
- Jazz Pharmaceuticals (JAZZ) Stock Price & Overview
- Jazz Pharmaceuticals (JAZZ) Stock Price & Overview
- Jazz Pharmaceuticals plc, JAZZ, FDA Calendar, PDUFA Date - RTTNews
- jazz-20260915
- Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
JAZZ research tape
52 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.